FdaApplication
ANDA 206077
Identifiers
- fda_app_no: ANDA206077
Properties
| Property | Value |
|---|---|
| applicant_name | FRESENIUS KABI USA LLC |
| application_type | ANDA |
| approval_date | 2018-04-11 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DAPTOMYCIN | DAPTOMYCIN | 500MG/VIAL | POWDER;INTRAVENOUS |
1 product